Searchable abstracts of presentations at key conferences in endocrinology

ea0034p338 | Reproduction | SFEBES2014

The melanocortin system in the male reproductive axis

Dowejko Monika , Smith Caroline , Getting Stephen , Le Tissier Paul R , Murray Joanne F

Melanocortin receptors (MCS, MC1–MC5) are GPCRs, activated with different affinities by the melanocortin peptides (α-, β-, γ-MSH and ACTH). They are widely distributed throughout the body displaying a multitude of actions however their role in reproductive physiology is unclear. Previously, we have shown a reduction of pituitary hormone content and abnormalities in testes morphology in male MC3 null mice. The aim ...

ea0033p8 | (1) | BSPED2013

Reliability of diagnostic tests for paediatric Cushing's syndrome

Guemes Maria , Murray Phil , Brain Caroline , Peters Catherine , Spoudeas Helen , Hindmarsh Peter , Dattani Mehul

Introduction: Cushing’s syndrome is a rare and life-threatening paediatric disease, the diagnosis of which can be challenging given its heterogeneous clinical presentation and the investigation results which are frequently inconclusive.Aim: To assess the reliability of the tests used for screening and for establishing the aetiology of Cushing’s syndrome.Design: We conducted a retrospective study analyzing cases of Cushing...

ea0032p49 | Adrenal cortex | ECE2013

European Adrenal Insufficiency Registry: a comparative observational study of glucocorticoid replacement therapy

Eckman Bertil , Fitts David , Marelli Claudio , Murray Robert , Quinkler Marcus , Zelissen Pierre

Introduction: A once-daily modified-release formulation of hydrocortisone (Plenadren®) has been developed to better mimic physiological cortisol secretion in the treatment of patients with adrenal insufficiency (AI). Here, we describe EU-AIR, an ongoing post-authorization observational study (registry) designed to collect information on AI management and to assess the long-term safety of Plenadren® compared with traditional glucocorticoid replac...

ea0025p248 | Pituitary | SFEBES2011

Thyroid function in patients with pituitary disease: difficulties of individualisation

El-Laboudi Ahmed , Lynch Julie , Baxter Paul , Barth Julian , Murray Robert

Introduction: Identification and treatment of central hypothyroidism in hypopituitarism is crucial particularly in patients with significant lethargy under consideration for GH replacement. Early Identification of TSH deficiency can be challenging particularly when both the TSH and fT4 lie within the normal range.Methods: 26 362 TFTs derived from ambulatory community dwelling individuals represented the control group. TFTs from 227 patients with a putati...

ea0025p257 | Pituitary | SFEBES2011

Thyroid function in patients with pituitary disease: difficulties of individualisation

El-Laboudi Ahmed , Lynch Julie , Baxter Paul , Barth Julian , Murray Robert

Introduction: Identification and treatment of central hypothyroidism in hypopituitarism is crucial particularly in patients with significant lethargy under consideration for GH replacement. Early Identification of TSH deficiency can be challenging particularly when both the TSH and fT4 lie within the normal range.Methods: 26 362 TFTs derived from ambulatory community dwelling individuals represented the control group. TFTs from 227 patients wi...

ea0024oc1.6 | Oral Communications 1 | BSPED2010

Altered Metabolomic Profile in Children Born Small for Gestational Age without Post-Natal Catch-up Growth

Butcher I , Murray P , Brown M , Dunn W , Westwood M , Clayton PE

Background: Approximately 1000 children per annum born small for gestational age (SGA) will fail to catch-up and become eligible for GH treatment. The reason for this failed growth is often not defined. Understanding mechanisms that cause growth failure in SGA and finding potential biomarkers of poor growth is therefore important. We are using the new technique of Metabolomics as one avenue to address this. Metabolomics is the quantification of small molecule metabolites in a ...

ea0024p16 | (1) | BSPED2010

IGF-2 deficiency in the growth disorder 3-M syndrome

Murray P , Hanson D , Whatmore A , Black G C M , Clayton P E

Introduction: 3-M syndrome is an autosomal recessive disorder characterised by pre- and postnatal growth restriction, characteristic facial dysmorphism, normal intelligence and radiological features (slender long bones and tall vertebral bodies). It is known to be caused by mutations in the genes encoding Cullin 7 (a component of the ubiquitination system) and Obscurin like-1 (a cytoskeletal protein). The mechanisms through which mutations in these genes impair growth are uncl...

ea0023oc1.6 | Oral Communications 1 | BSPED2009

Influence of JAK2 and PI3 kinase genotypes on growth response to GH therapy

Omokanye A , Solomon M , Morjaria R , Murray P , Whatmore A , Patel L , Clayton P

Carriage of the exon 3 deletion in the GH receptor (GHR) gene has been reported to enhance growth response to GH therapy. JAK2 and PI3K are involved in signal transduction from the GH (JAK2/PI3K) and IGF1 (PI3K) receptors. We have investigated whether a single nucleotide polymorphism within these genes influences growth response to GH therapy. DNA was taken, with ethical approval, from 104 children treated with GH therapy. Diagnoses were: GHD (n=44), TS (n=23), S...

ea0021pl8 | Clinical Endocrinology Trust Lecture | SFEBES2009

Ubiquitination: the ‘Kiss of Death' for human growth

Clayton Peter E , Hanson Dan , Murray Philip , Sud Amit , Black Graeme

Ubiquitination (Ub) is the process that controls the level and activity of cellular proteins. Mono-ubiquitination of a protein alters its function, while poly-ubiquitination targets a protein for degradation (as the ‘kiss of death’). Alterations in the Ub system are associated with a wide range of disease, e.g. cancer, neurological diseases and viral infection.Disorders of growth where the phenotype is primarily short stature are usually caused...

ea0021p385 | Thyroid | SFEBES2009

Atypical presentation of Riedel’s thyroiditis: multifocal nodular fibrosis and resolution with levothyroxine

Kumar Sampath Satish , Sheila Fraser , Scarsbrook Andrew , Maclennan Ken , Lansdown Mark , Murray Robert

In patients presenting with a diffusely enlarged hard thyroid gland the differential diagnosis lies between thyroid carcinoma, lymphoma, and Riedel’s thyroiditis. We present a case of Riedel’s thyroiditis with multifocal nodular sclerosis, which improved with levothyroxine replacement.A 40-year-old woman presented with a 3 months history of neck swelling, dysphagia and breathlessness on exertion. Examination revealed a hard, fixed, diffuse goit...